全文获取类型
收费全文 | 26844篇 |
免费 | 2004篇 |
国内免费 | 734篇 |
专业分类
耳鼻咽喉 | 661篇 |
儿科学 | 522篇 |
妇产科学 | 702篇 |
基础医学 | 1819篇 |
口腔科学 | 524篇 |
临床医学 | 3091篇 |
内科学 | 8880篇 |
皮肤病学 | 31篇 |
神经病学 | 254篇 |
特种医学 | 1203篇 |
外国民族医学 | 2篇 |
外科学 | 5263篇 |
综合类 | 3397篇 |
现状与发展 | 1篇 |
预防医学 | 554篇 |
眼科学 | 1019篇 |
药学 | 969篇 |
8篇 | |
中国医学 | 272篇 |
肿瘤学 | 410篇 |
出版年
2024年 | 50篇 |
2023年 | 586篇 |
2022年 | 898篇 |
2021年 | 1617篇 |
2020年 | 1494篇 |
2019年 | 1423篇 |
2018年 | 1301篇 |
2017年 | 968篇 |
2016年 | 894篇 |
2015年 | 946篇 |
2014年 | 1816篇 |
2013年 | 1723篇 |
2012年 | 1211篇 |
2011年 | 1428篇 |
2010年 | 1132篇 |
2009年 | 1135篇 |
2008年 | 1063篇 |
2007年 | 1091篇 |
2006年 | 1046篇 |
2005年 | 965篇 |
2004年 | 737篇 |
2003年 | 738篇 |
2002年 | 658篇 |
2001年 | 596篇 |
2000年 | 454篇 |
1999年 | 445篇 |
1998年 | 364篇 |
1997年 | 312篇 |
1996年 | 326篇 |
1995年 | 280篇 |
1994年 | 236篇 |
1993年 | 218篇 |
1992年 | 177篇 |
1991年 | 151篇 |
1990年 | 139篇 |
1989年 | 123篇 |
1988年 | 92篇 |
1987年 | 100篇 |
1986年 | 102篇 |
1985年 | 105篇 |
1984年 | 101篇 |
1983年 | 63篇 |
1982年 | 67篇 |
1981年 | 41篇 |
1980年 | 48篇 |
1979年 | 26篇 |
1978年 | 26篇 |
1977年 | 13篇 |
1976年 | 19篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
51.
Objective Reduction ascending aortoplasty is an alternative procdure to the replacement of the ascending aorts in case of ascending aorta dilation. However,its applicabikity is still under debate.This retrospective study was designed to evaluuate the midterm follow-up of unsupported ascending reduction aortoplasty for of the ascending aorta in petients with aortic valve dis- ease.Methods From October ,1996 to April,2007, a total of 54 patients with aortic valve disease and dilatation of the ascending aorta underwent unsupported reduction aortoplasty in combination with aortic valve replacement at our institution The diameter of the ascending aorta was measyred before and early after sugery and then later between 13 and 96 menths [mean (23 ±16)months] posto- perativeiy using echocardiography.Results Two patients were dead with thean overall perioperative mortality rate was of 3.7%. The reduction aortoplasty decreased the diameter of the aorta from (45.77±6.02) mm p~eope~afive]y to (34.67 ~4.81) mm early after surgery (P<0.01). During follow-up, the diameter d aorta increased from (34.67±4.81) mm early after surgery to (37.65± 6.35) mm after a mean follow-up of (23±16) months (P<0.01), including the diameters are greater than > 45 mm within 5 pa- tients. Aortic stenosis and an early postoperative diameter greater than 40 mm m'e independent risk factors for redilatation. Conchusion Because of the unsatisfied midterm follow-up redilation of unsupported reduction aortoplasty for dilation of the ascending aorta with aortic valve disease, this group of patients needs continued intimate fallow-up or even reoperation. The patients of stenosis is the surtable indication for RAA, and it is necessary to reduce the diameter of aorta to be lees than 40 mm to prevent redilation. 相似文献
52.
17β-雌二醇对子宫内膜异位症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响 总被引:2,自引:0,他引:2
目的研究17β-雌二醇(17β-E2)对子宫内膜异位症(内异症)患者在位子宫内膜间质细胞β-catenin mRNA和蛋白表达的影响,探讨Wnt/β-catenin信号通路在介导雌激素促进内异症发生发展的作用。方法体外分离培养内异症患者在位子宫内膜间质细胞。用不同浓度17β-E2处理子宫内膜间质细胞48 h;此后选用10-10mol/L 17β-E2处理子宫内膜间质细胞12、24和48 h,逆转录聚合酶链反应(RT-PCR)和免疫印迹法(Western blotting)检测17β-E2处理前后子宫内膜间质细胞β-catenin mRNA和蛋白的表达水平。同法分析雌激素受体拮抗剂ICI182,780(10-6mol/L)对17β-E2促进β-catenin mRNA和蛋白表达的影响。免疫组织化学染色观察17β-E2作用后β-catenin在子宫内膜间质细胞中的定位。结果17β-E2能明显促进内异症患者在位子宫内膜间质细胞β-catenin mRNA和蛋白的表达,并呈剂量和时间依赖性,于10-10mol/L作用48 h最明显。雌激素受体拮抗剂ICI182,780能明显抑制17β-E2对子宫内膜间质细胞β-catenin mRNA和蛋白的表达。免疫组织化学染色发现17β-E2能促进β-catenin在子宫内膜间质细胞核内的表达。结论雌激素可能通过激活Wnt/β-catenin信号通路促进内异症在位子宫内膜的异位种植。 相似文献
53.
血管内修复术创伤性小,可应用于治疗多种主动脉疾病,如动脉瘤和主动脉夹层。经食管超声心动图(TEE)对主动脉疾病很敏感。术前可通过TEE找到撕裂的内膜片、发现内膜破口、区分类型、区分真假腔及了解心脏状况。术中TEE用于引导导管插至正确位置、观察支架放置过程、监测心功能和室壁运动状况、评价手术疗效。术后随诊通过TEE观察支架内血流情况、检出并发症如内漏等。 相似文献
54.
Yoshimasa Sakamoto Kazuhiro Hashimoto Hiroshi Okuyama Shinichi Ishii Takahiro Inoue Katsushi Kinouchi Takayuki Abe 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2005,53(9):465-469
Objective The objective of the present study was to compare long-term results of single aortic valve replacement (AVR) with mechanical
(St. Jude Medical valves: standard) and biologic (the Carpentier-Edwards pericardial) prostheses. Method: Between 1995 and 2002, 95 patients who underwent single AVR with mechanical (n=46) or biologic (n=49) prostheses were enrolled
in this study. The mean age at the operation was 54.0±9.6 years (range: 20 to 69 years) with the mechanical and 68.8±7.1 years
(range: 44 to 85 years) with the biologic prosthesis. Results: The 9-year actuarial survival rate, which was calculated by taking perioperative mortality into account, was 90.3±4.6% for
patients with mechanical valves and 87.6 ±4.8% for patients with bioprostheses, with no difference between the two groups
(p=0.342). The 9-year freedom rate from thromboembolism, reoperation, endocarditis was 94.8+3.6%, 100% and 97.8 ±2.2% for
patients with mechanical valves and 98.0 ±2.0%, 97.5 ±3.4% and 95.0 ±3.4% for those with bioprostheses, respectively. After
9 years, freedom from cardiac death averaged 97.8% in the group with mechanical valves compared with 95.3% in those with bioprostheses
(p=0.541). Conclusion: We conclude that the mid-term durability of the Carpentier-Edwards pericardial valve in the aortic position for the elderly
is excellent. Nevertheless, the risk of tissue valve reoperation progressively increases with time, and a longer follow-up
may be necessary to provide its value compared with the mechanical valves in a country like Japan with a high life expectancy.
(Jpn J Thorac Cardiovasc Surg 2005; 53:465-469) 相似文献
55.
老年腹主动脉瘤非手术治疗的长期超声随访研究 总被引:5,自引:0,他引:5
目的超声随访观察经非手术治疗的老年腹主动脉瘤的发展变化规律。方法超声随访诊断明确、病历及影像学资料完整的老年腹主动脉瘤非手术治疗患者37例,按首次发现时瘤体大小分3组,定期测量并记录各组腹主动脉扩张最明显处横切面直径,计算年增长量。结果37例腹主动脉瘤首次发现时瘤径大小平均为4.68cm,随访年限0.5~11年,平均6.1年,瘤径平均每年增长0.47cm。14例瘤径小于4.0cm,平均年增长0.23cm,15例瘤径小于6.0cm,平均年增长0.37cm,8例瘤径大于6.0cm,平均年增长0.67cm。随访期间死亡5例,其中因动脉瘤破裂死亡2例,破裂前瘤径大小分别为8.35cm、8.91cm。7例随访期间因瘤径短期内明显增大而行腹主动脉瘤腔内支架隔绝术。结论老年腹主动脉瘤瘤径小于6.0cm者随增龄增长缓慢,大于6.0cm者随增龄增长快,应进行积极的外科干预。 相似文献
56.
立体着床模型--小鼠囊胚与子宫内膜的共培养 总被引:1,自引:0,他引:1
目的:建立小鼠囊胚体外着床的三维模型,为着床机制的研究提供重要工具.方法:将小鼠囊胚与其自身子宫内膜分别共培养在空气、含500,750和950 mL/L O2的混合气体与组织培养液的气液界面上,比较不同O2浓度下小鼠囊胚的贴附率,确定体外共培养的最佳O2浓度;同时将确认有囊胚贴附的子宫内膜取出作HE染色.结果:不同O2浓度下,囊胚的贴附率分别为64.75%,47.86%,42.37%和30.97%,x2检验提示其差异有显著性(x2=28.145,P=0.000);且随着混合气体中O2浓度的逐渐升高,囊胚贴附率呈逐渐降低趋势.因此50 mL/L CO2 950 mL/L空气对囊胚与子宫内膜的共培养是最有利的;同时,囊胚贴附子宫内膜后并无扩展行为而是直接侵入子宫内膜.结论:50 mL/L CO2 950 mL/L空气最有利于囊胚与子宫内膜的共培养;且囊胚贴附子宫内膜后不发生外延生长,而是直接侵入子宫内膜.本实验成功地建立了小鼠囊胚体外着床的三维模型. 相似文献
57.
MRI在心脏瓣膜病中的诊断价值 总被引:1,自引:0,他引:1
目的 探讨多序列MR扫描在心脏瓣膜病中的诊断价值。方法 回顾性分析56例心脏瓣膜病患者的影像学资料,患者分别采用超声心动图(UCG)、二维(2D)黑血及亮血序列、K-空间节段真实稳态进动快速扫描序列(True FISP)对瓣膜病进行定性评价,15例患者还进行小角度快速激发(FLASH)电影序列和流速编码电影(VEC)定量分析,并将MR结果与UCG进行对比。结果 UCG和MRI诊断二尖瓣狭窄(MS)2例,二尖瓣关闭不全(MI)23例;主动脉瓣狭窄(AS)7例,其中二瓣畸形5例;主动脉瓣关闭不全(AI)13例;三尖瓣关闭不全(TI)2例;复合或联合瓣膜病9例。受累心腔的增大和升主动脉的扩张是其主要形态学改变,异常的血液湍流信号是受累瓣膜的直接征象。VEC-MR定量分析与多普勒超声一致性好:6例AS,MR和UCG检查结果相关性分析,相关系数和校正相关系数分别为:R=0,975、Rsq=0.951(P〈0.01),AI9例,分别为R=0.965、Rsq=0.932(P〈0.01)。结论 MR多序列综合扫描可对心脏瓣膜病特别是主动脉瓣疾病进行准确的定性及定量评价。 相似文献
58.
Portsite and intraabdominal metastases of unsuspected gallbladder carcinoma after laparoscopic cholecystectomy: Report of a case 总被引:1,自引:0,他引:1
Nobuhiro Shibata Katsumi Kagotani Sadao Noguchi Masamitsu Tamai 《Surgery today》1996,26(12):1014-1016
We herein report a rare case of portsite metastasis of gallbladder carcinoma which occurred after laparoscopic cholecystectomy. A 64-year-old man underwent laparoscopic cholecystectomy at another hospital for symptomatic cholecystolithiasis. The histological examination revealed an adenocarcinoma of the gallbladder infiltrating the entire wall. Despite the physician's advice the patient refused any additional treatment. Thirteen months after surgery he visited our hospital because of a palpable mass at the scar of the right trocar incision. The nodule was removed and histological examination confirmed metastasis from the gallbladder carcinoma. 相似文献
59.
R. Lazzara A. A. Siddiqui P. Binon S. A. Feldman R. Weiner R. Phillips A. Gonshor 《Clinical oral implants research》1996,7(1):73-83
Osseointegrated dental implants have now become an accepted form of treatment for patients with a fully or partially missing dentition. The purpose of this study was to evaluate the performance of 3i threaded and cylindrical implants. During a 5-year period, a total of 1969 3i endosseous implants were placed at 6 centers in the United States and 2 elsewhere in the edentulous and partially edentulous jaws of 653 consecutive patients ranging in age from 18 to 82 years. Of the total number of implants placed, 1341 were commercially pure titanium threaded implants and 628 were titanium plasma-sprayed implants with a cylindrical configuration. A total of 28 patients with 110 implants were lost to follow-up. Implants in these patients were considered neither a success nor a failure. Success was predicated on the osseointegration of each and every implant followed in this analysis rather than the persistence of prosthetic function. Confirmed bone anchorage was considered essential for success. A total of 625 patients with 1871 implants remain in the study with a follow-up period ranging from 6 to 60 months. A total of 93 implants (5.0% of the total implants followed) were considered as failures. A mean implant survival rate was 95.0% for both the threaded and the cylindrical implant was calculated. The success rate of threaded implants was 97.0% in the mandible and 93.8% in the maxilla. The success rate for the 3.3mm cylindrical implants was 96.0% in the mandible and 95.5% in the maxilla, and the success rate of 4.0mm diameter cylindrical implants was 95% in the mandible and 92.0% in the maxilla. Causes of failure consisted of loss of osseointegration 2.3%crestal bone loss requiring periodontal therapy after the first year of function 1.7% and mechanical problems associated with the prosthesis 0.9%. This retrospective analysis of the 3i endosseous implant system is comparable to previous reports on other implant systems in terms of implant survival and prosthesis stability. It is demonstrated that 3i implants are predictable and can provide lasting osseointegration leading to improvement of oral function if the recommended surgical and restorative protocol is followed. 相似文献
60.
应用同种动脉治疗主动脉根部病变 总被引:4,自引:0,他引:4
报告5例采用同种动脉(HAV)治疗5例主动脉根部病变(主动脉瓣狭窄1例,关闭不全4例)。男3例,女2例;年龄13~47岁。病因为细菌性心内膜炎2例(包括先天主动脉瓣二瓣化畸型1例),Marfan综合征2例,风湿性主动脉瓣关闭不全1例。术中采用同种主动脉全根置换3例(Bentall手术),其中1例用HAV上的二尖瓣前叶加宽主动脉瓣环(Manouguian手术),余2例用自体肺动脉移置主动脉根部,另取同种肺动脉做原位移置(Ross手术)。结果死亡1冽,4例存活,且无并发症发生。术后超声心动图提示主动脉根部良好,无主动脉瓣反流。随访2.5~3.5年疗效满意。 相似文献